Gaucher disease: heterologous expression of two alleles associated with neuronopathic phenotypes.
- 1 September 1991
- journal article
- Vol. 49 (3) , 646-55
Abstract
To investigate the molecular basis for the distinct neuronopathic phenotypes of Gaucher disease, acid beta-glucosidases expressed from mutant DNAs in Gaucher disease type 2 (acute) and type 3 (subacute) patients were characterized in fibroblasts and with the baculovirus expression system in insect cells. Expression of the mutant DNA encoding a proline-for-leucine substitution at amino acid 444 (L444P) resulted in a catalytically defective, unstable acid beta-glucosidase in either fibroblasts from L444P/L444P homozygotes or in insect cells. This mutation was found to be homoallelic in subacute neuronopathic (type 3) Gaucher disease. In comparison, expression of the mutant cDNA encoding an arginine-for-proline substitution at amino acid 415 (P415R) resulted in an inactive and unstable protein in insect cells. This allele was found only in a type 2 patient with the L444P/P415R genotype. The substantial variation in the type 3 phenotype (L444P homozygotes) suggests the complex nature of the molecular basis of phenotypic variation in Gaucher disease. Yet, the association of neuronopathic phenotypes with alleles producing severely compromised (L444P) or functionally null (P415R) enzymes indicates that the effective level of residual activity at the lysosome is likely to be a major determinant of the severity of Gaucher disease.This publication has 48 references indexed in Scilit:
- Hazards and their exploitation in the applications of molecular biology to structure-function relationshipsBiochemistry, 1990
- Mutation analysis of an Ashkenazi Jewish family with gaucher disease in three successive generationsAmerican Journal of Medical Genetics, 1990
- Gaucher disease associated with a unique Kphl restriction site: identification of the amino‐acid substitutionAnnals of Human Genetics, 1990
- PREDICTION OF SEVERITY OF GAUCHER'S DISEASE BY IDENTIFICATION OF MUTATIONS AT DNA LEVELThe Lancet, 1989
- In vitro detergent activation of lysosomal acid β-glucosidase in the spleen of normal and type 1 Gaucher patients is not accompanied by change in aggregation stateBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989
- Human acid β-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sitesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1987
- A Mutation in the Human Glucocerebrosidase Gene in Neuronopathic Gaucher's DiseaseNew England Journal of Medicine, 1987
- Genetic heterogeneity in Gaucher disease: Physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non‐neuronopathic and neuronopathic patientsAmerican Journal of Medical Genetics, 1985
- Modification of subunit interaction in membrane‐bound acid β‐glucosidase from Gaucher diseaseFEBS Letters, 1983
- Partial Enzyme Deficiencies: Residual Activities and the Development of Neurological DisordersDevelopmental Neuroscience, 1983